author-photo

Juan De la Cámara

9

Papers

22

Citations

Citation Trend

Filter By

Papers (7) Sort By

Journal Conference Others

Effect of antiangiogenic-based treatment and systemic inflammatory factors on outcomes in patients with BRAF v600-mutated metastatic colorectal cancer: a real-world study in Spain.

2021 BMC Cancer
Show All
- Source
- Cite
- Save
Citations (0)
Identification of the optimal patients for trifluridine/tipiracil (FTD/TPI) treatment in mCRC: A Spanish real-world analysis.

2020 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)
P-191Randomized phase II clinical trial to evaluate the efficacy of second-line FOLFIRI-panitumumab in patients with RAS wild-type metastatic colorectal cancer who have received FOLFOX-panitumumab in first-line (BEYOND)

2019 Annals of Oncology
Show All
- Source
- Cite
- Save
Citations (0)
P-266Retrospective analysis of clinical factors associated with a greater benefit with Trifluridine and Tipiracil in metastasic colorectal cancer

2018 Annals of Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Prognostic factors for survival with nab-paclitaxel plus gemcitabine in metastatic pancreatic cancer in real-life practice: the ANICE-PaC study

2018 BMC Cancer
Show All
- Source
- Cite
- Save
Citations (13)
BRAF (V600E) mutant metastatic colorectal cancer: What is the role of the antiangiogenic therapy in a real-world setting?

2018 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Predicting Outcome and Therapy Response in mCRC Patients Using an Indirect Method for CTCs Detection by a Multigene Expression Panel: A Multicentric Prospective Validation Study

2017 International Journal of Molecular Sciences
Show All
- Source
- Cite
- Save
Citations (9)